BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 29 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | – | 529 | +66.9% | 0.00% | – |
| Q1 2024 | $0 | – | 317 | -41.7% | 0.00% | – |
| Q4 2023 | $0 | – | 544 | -72.5% | 0.00% | – |
| Q3 2023 | $0 | -100.0% | 1,975 | -20.3% | 0.00% | – |
| Q2 2023 | $5,000 | 0.0% | 2,478 | +61.6% | 0.00% | – |
| Q1 2023 | $5,000 | +66.7% | 1,533 | 0.0% | 0.00% | – |
| Q4 2022 | $3,000 | -57.1% | 1,533 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +75.0% | 1,533 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 1,533 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -16.7% | 1,533 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | +20.0% | 1,533 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 1,533 | -18.1% | 0.00% | – |
| Q2 2021 | $7,000 | -81.1% | 1,872 | -80.2% | 0.00% | – |
| Q1 2021 | $37,000 | -32.7% | 9,436 | -21.3% | 0.00% | – |
| Q4 2020 | $55,000 | -71.1% | 11,988 | +6.7% | 0.00% | – |
| Q3 2020 | $190,000 | +31.0% | 11,231 | -13.1% | 0.00% | – |
| Q2 2020 | $145,000 | +145.8% | 12,931 | +1.5% | 0.00% | – |
| Q1 2020 | $59,000 | +40.5% | 12,741 | +30.1% | 0.00% | – |
| Q4 2019 | $42,000 | +7.7% | 9,796 | -3.4% | 0.00% | – |
| Q3 2019 | $39,000 | 0.0% | 10,143 | +3.5% | 0.00% | – |
| Q2 2019 | $39,000 | -7.1% | 9,796 | 0.0% | 0.00% | – |
| Q1 2019 | $42,000 | +23.5% | 9,796 | +2.8% | 0.00% | – |
| Q4 2018 | $34,000 | -5.6% | 9,533 | -0.4% | 0.00% | – |
| Q3 2018 | $36,000 | -2.7% | 9,575 | +0.4% | 0.00% | – |
| Q2 2018 | $37,000 | +23.3% | 9,533 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | +66.7% | 9,533 | +110.3% | 0.00% | – |
| Q4 2017 | $18,000 | 0.0% | 4,533 | -0.2% | 0.00% | – |
| Q3 2017 | $18,000 | +5.9% | 4,544 | +12.7% | 0.00% | – |
| Q2 2017 | $17,000 | 0.0% | 4,033 | 0.0% | 0.00% | – |
| Q1 2017 | $17,000 | +183.3% | 4,033 | +59.2% | 0.00% | – |
| Q4 2016 | $6,000 | -78.6% | 2,533 | -78.0% | 0.00% | – |
| Q3 2016 | $28,000 | 0.0% | 11,533 | 0.0% | 0.00% | – |
| Q2 2016 | $28,000 | -6.7% | 11,533 | 0.0% | 0.00% | – |
| Q1 2016 | $30,000 | +3.4% | 11,533 | +15.0% | 0.00% | – |
| Q4 2015 | $29,000 | +81.2% | 10,033 | +42.7% | 0.00% | – |
| Q3 2015 | $16,000 | +300.0% | 7,033 | +580.8% | 0.00% | – |
| Q2 2015 | $4,000 | 0.0% | 1,033 | 0.0% | 0.00% | – |
| Q1 2015 | $4,000 | -20.0% | 1,033 | 0.0% | 0.00% | – |
| Q4 2014 | $5,000 | +150.0% | 1,033 | +93.8% | 0.00% | – |
| Q3 2014 | $2,000 | – | 533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 400,000 | $1,068,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 493,191 | $1,317,000 | 0.07% |
| GUARDIAN CAPITAL ADVISORS LP | 10,000 | $23,000 | 0.00% |
| A.R.T. Advisors, LLC | 22,758 | $60,000 | 0.00% |
| Psagot Value Holdings Ltd. | 22,715 | $61,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 1,100 | $3,000 | 0.00% |
| Penserra Capital Management LLC | 4,980 | $13,000 | 0.00% |
| D'Orazio & Associates, Inc. | 500 | $1,000 | 0.00% |
| CITIGROUP INC | 380 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,269 | $163,000 | 0.00% |